Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
|
| Pubblicazione: | Washington : , : U.S. Government Publishing Office, , 2018 |
| Descrizione fisica: | 1 online resource (iv, 51 pages) |
| Soggetto topico: | Drugs - United States - Testing |
| Drug approval - United States | |
| Drugs - Safety regulations - United States | |
| Medical instruments and apparatus - Safety regulations - United States | |
| Generic drugs - United States | |
| Competition - United States | |
| Antitrust law - United States | |
| Antitrust law | |
| Competition | |
| Drug approval | |
| Drugs - Safety regulations | |
| Drugs - Testing | |
| Generic drugs | |
| Medical instruments and apparatus - Safety regulations | |
| Soggetto geografico: | United States |
| Soggetto genere / forma: | Legislative hearings. |
| Rules. | |
| Note generali: | "Serial no. 115-27." |
| Altri titoli varianti: | Antitrust concerns and the FDA approval process |
| Titolo autorizzato: | Antitrust concerns and the FDA approval process |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910709758903321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |